Exploring Registry-Based Randomised Controlled Trials in Australia
Author Information
Author(s): Karanatsios Bill, Prang Khic-Houy, Yeung Justin M., Gibbs Peter
Primary Institution: The University of Melbourne
Hypothesis
What are the perceptions of stakeholders regarding the capacity and capability of registry-based randomised controlled trials (RRCTs) in Australia?
Conclusion
RRCTs are increasingly recognized as a beneficial alternative methodology in Australia, but face several barriers to effective implementation.
Supporting Evidence
- RRCTs can recruit more real-world patients and leverage existing registry platforms for data collection.
- Barriers to RRCT uptake include inadequate funding and low awareness of the methodology.
- RRCTs are seen as simpler and more cost-effective compared to traditional RCTs.
Takeaway
This study talks to doctors and researchers about a new way to run medical trials that could save money and help more people, but they need more support and awareness to make it happen.
Methodology
The study conducted 30 semi-structured interviews with clinicians, research program managers, and research governance officers, analyzing the data using thematic analysis.
Potential Biases
Potential selection bias due to the recruitment of participants known to the authors.
Limitations
The study may not represent the views of all stakeholders as it primarily included participants known to the authors and lacked diversity in regional representation.
Participant Demographics
Participants included 18 clinician researchers, 6 research program managers, and 6 research governance officers, with varied levels of RRCT awareness.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website